PACE: Pharmacists use the power of communication in paediatric asthma

Amanda Elaro1, Smita Shah, Luca N Pomare

  • 1The Woolcock Institute of Medical Research, University of Sydney, Glebe, NSW, 2051, Australia, aela5708@uni.sydney.edu.au.

Insights

The Practitioner Asthma Communication and Education (PACE) program was successfully adapted for community pharmacists, improving their paediatric asthma communication and education skills. This initiative demonstrates pharmacists

Area of Science:

  • Pharmacy Practice
  • Respiratory Medicine
  • Health Professional Education

Background:

  • Paediatric asthma presents a significant public health challenge in Australia, underscoring the need for effective interventions.
  • Existing national asthma guidelines are underutilized, and community pharmacy-based programs for paediatric asthma are limited.
  • The Practitioner Asthma Communication and Education (PACE) program, originally for physicians, has proven effective in improving paediatric asthma management.

Purpose of the Study:

  • To adapt the evidence-based PACE program for application in community pharmacy settings.
  • To assess the feasibility and acceptability of the adapted PACE program for pharmacists.
  • To explore the program's impact on pharmacists' communication skills and asthma management practices.

Main Methods:

  • The PACE framework was modified to create 'PACE for Pharmacy', tailored for community pharmacists.
  • Forty-four pharmacists participated in interactive training workshops.
  • Pharmacist satisfaction, confidence in communication strategies, and self-reported behavioural changes were evaluated pre- and post-workshop.

Main Results:

  • A 100% retention rate was achieved, with high pharmacist satisfaction reported.
  • Pharmacists showed significantly increased confidence and use of communication strategies post-training.
  • Reported improvements included more frequent checks of asthma self-management plans, inhaler technique, and provision of verbal instructions for new medications.

Conclusions:

  • The PACE program is transferable to the community pharmacy setting, demonstrating positive effects on pharmacist communication and education.
  • PACE for Pharmacy effectively enhanced pharmacists' self-reported communication and teaching behaviours in paediatric asthma consultations.
  • The high engagement indicates pharmacists' readiness to expand their clinical roles in primary healthcare.
Abstract

Related Concept Videos

Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
399
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
954
Inhaled Medications01:23

Inhaled Medications

Inhaled medications are crucial for managing chronic obstructive pulmonary disease (COPD) and asthma. They are essential for effective treatment and control, ensuring optimal respiratory health and well-being. Inhaled medication delivers drugs directly to the lungs, providing a rapid onset of action and reducing systemic side effects compared to oral or injectable medications. Three primary types of inhalation devices are used to administer these medications: nebulizers, metered-dose inhalers...
1.1K
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
544
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
405